Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine Butyrate Injection vs Cleviprex in Hypertensive Emergencies
CTR20212877Phase 3Completed
- Sponsor
- Kelun Pharmaceutical
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevidipine in hypertensive emergency, hypertensive urgency, sponsored by Kelun Pharmaceutical. Started Nov 2021; status: completed.
02
Drugs
clevidipine
03
Conditions
hypertensive emergencyhypertensive urgency
Beyond the preview
Go deeper on CTR20212877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212877.